Maynard Um
-
-
-
-
-
-
-
NorthStrive transfers EL-32 cell bank to US facility for manufacturing
-
-
-
-
-
-
-
PMGC Holdings acquires SVM Machining for $2.25 million base price
-
-
-
-
-
-
-
Northstrive completes phase II of AI drug development program
-
-
-
-
-
-
-
Northstrive Biosciences (ELAB) Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
-
-
-
-
-
-
-
PMGC Holdings (ELAB) Receives $1.9M in Gross Proceeds from Warrant Inducement with Institutional Investors
-
-
-
-
-
-
-
Elevai Labs (ELAB) Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation
-
-
-
-
-
-
-
Elevai Labs' (ELAB) Elevai Skincare Reports Positive Results for E-Series Exosome Technology in Potential Melasma Applications
-
404,873 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

